Carbapenem‐ResistantEscherichia coliHarboringKlebsiella pneumoniaeCarbapenemase β‐Lactamases Associated with Long‐Term Care Facilities
Open Access
- 1 June 2008
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 46 (11) , e127-e130
- https://doi.org/10.1086/588048
Abstract
Nine carbapenem-resistant Escherichia coli isolates harboring Klebsiella pneumoniae carbapenemase (KPC)-2 or KPC-3 enzymes were identified in patientKeywords
This publication has 19 references indexed in Scilit:
- A Step Closer to Extreme Drug Resistance (XDR) in Gram-Negative BacilliClinical Infectious Diseases, 2007
- Carbapenemases: the Versatile β-LactamasesClinical Microbiology Reviews, 2007
- Ertapenem Resistance ofEscherichia coliEmerging Infectious Diseases, 2007
- Klebsiella pneumoniae Isolate Producing at Least Eight Different β-Lactamases, Including AmpC and KPC β-LactamasesAntimicrobial Agents and Chemotherapy, 2007
- Plasmid-Mediated Imipenem-Hydrolyzing Enzyme KPC-2 among Multiple Carbapenem-Resistant Escherichia coli Clones in IsraelAntimicrobial Agents and Chemotherapy, 2006
- Extended-Spectrum β-Lactamases: a Clinical UpdateClinical Microbiology Reviews, 2005
- Escherichia coli: Development of Carbapenem Resistance During TherapyClinical Infectious Diseases, 2005
- Preventing antimicrobial-resistant bacterial infections among older adults in long-term care facilitiesJournal of the American Medical Directors Association, 2005
- Broad Resistance Due to Plasmid‐Mediated AmpC β‐Lactamases in Clinical Isolates ofEscherichia coliClinical Infectious Diseases, 2002
- Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain ofKlebsiella pneumoniaeAntimicrobial Agents and Chemotherapy, 2001